Ignite Creation Date:
2025-12-25 @ 4:18 AM
Ignite Modification Date:
2026-03-08 @ 1:58 AM
Study NCT ID:
NCT04580420
Status:
RECRUITING
Last Update Posted:
2025-12-24
First Post:
2020-09-24
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Safety & Efficacy of DCR-PHXC in Patients With PH1 and ESRD
Sponsor:
Dicerna Pharmaceuticals, Inc., a Novo Nordisk company
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
DCR-PHXC-204
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None